Skip to content

The effect of telemonitoring on adherence to continuous positive airway pressure in sleep apnea hypopnea syndrome

The effect of Telemonitoring on adherence at one year to Continuous Positive Airway Pressure in sleep apnea hypopnea syndrom: A randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN12865936
Enrollment
120
Registered
2017-01-26
Start date
2017-01-16
Completion date
Unknown
Last updated
2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea Hypopnea Syndrome Respiratory Sleep Apnea Hypopnea Syndrome

Interventions

Participants are referred to the trial through the diagnosis of sleep apnea-hypopnea syndrome (SAHS) and prescription for continuous positive airway pressure (CPAP) by a pneumologist. Participants wil

Sponsors

Ligue Pulmonaire Genevoise
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Diagnosis of Sleep apnea hypopnea syndrome 2. The Apnea Hypopnea Index (AHI) recorded as greater than 15 per hour 3. Patient starting CPAP therapy 4. Over the age of 18

Exclusion criteria

Exclusion criteria: 1. Previously treated for SAHS 2. Pregnant or nursing

Design outcomes

Primary

MeasureTime frame
Mean CPAP use (hours/day) is measured by reviewing the downloaded data of the CPAP machine at 3 months and 12 months.

Secondary

MeasureTime frame
1. Percentage of adherent patients (>4h/day) is measured by reviewing the downloaded data of the CPAP machine at 3 months and 12 months 2. Percentage of treatment discontinuation is measured by reviewing the downloaded data of the CPAP machine at 3 months and 12 months 3. Time of nursing work in minutes measured using a chronometer. The time of nursing work is recorded at the end of each appointment on a specific sheet

Countries

Switzerland

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 15, 2026